Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 8 | 2023 | 9981 | 0.720 |
Why?
|
| PPAR alpha | 4 | 2017 | 197 | 0.650 |
Why?
|
| PPAR-beta | 1 | 2015 | 5 | 0.550 |
Why?
|
| Metabolomics | 4 | 2021 | 1484 | 0.510 |
Why?
|
| PPAR gamma | 2 | 2016 | 493 | 0.460 |
Why?
|
| Mutagens | 1 | 2013 | 168 | 0.450 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2013 | 191 | 0.430 |
Why?
|
| Hyperglycemia | 1 | 2020 | 1373 | 0.400 |
Why?
|
| Carcinogens | 1 | 2013 | 466 | 0.390 |
Why?
|
| Eicosanoids | 3 | 2017 | 279 | 0.350 |
Why?
|
| Liver | 3 | 2016 | 7474 | 0.350 |
Why?
|
| Coronary Disease | 1 | 2022 | 6077 | 0.290 |
Why?
|
| Brain Ischemia | 1 | 2020 | 3265 | 0.280 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3086 | 0.260 |
Why?
|
| Lipid Metabolism | 4 | 2016 | 1889 | 0.230 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2015 | 402 | 0.220 |
Why?
|
| Hypoxanthine | 1 | 2022 | 28 | 0.220 |
Why?
|
| Pseudouridine | 1 | 2022 | 24 | 0.210 |
Why?
|
| Guanosine | 1 | 2022 | 61 | 0.210 |
Why?
|
| Phospholipids | 2 | 2017 | 784 | 0.200 |
Why?
|
| Nucleosides | 1 | 2022 | 138 | 0.200 |
Why?
|
| Gluconates | 1 | 2020 | 29 | 0.190 |
Why?
|
| Liver Regeneration | 2 | 2020 | 210 | 0.170 |
Why?
|
| Malates | 1 | 2019 | 33 | 0.170 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 78 | 0.160 |
Why?
|
| Succinic Acid | 1 | 2019 | 83 | 0.160 |
Why?
|
| Brain Edema | 1 | 2022 | 617 | 0.150 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 202 | 0.150 |
Why?
|
| Cyclohexylamines | 1 | 2016 | 21 | 0.150 |
Why?
|
| Fatty Acids | 3 | 2024 | 1809 | 0.140 |
Why?
|
| Altitude | 1 | 2017 | 161 | 0.140 |
Why?
|
| Epoxide Hydrolases | 1 | 2016 | 122 | 0.140 |
Why?
|
| Incidence | 3 | 2023 | 20947 | 0.130 |
Why?
|
| Diet | 3 | 2023 | 7939 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2024 | 1265 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 838 | 0.130 |
Why?
|
| Uric Acid | 1 | 2020 | 766 | 0.120 |
Why?
|
| Triazines | 1 | 2016 | 315 | 0.120 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2014 | 201 | 0.120 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 1018 | 0.110 |
Why?
|
| Rats | 5 | 2017 | 24260 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 577 | 0.110 |
Why?
|
| Heart Atria | 1 | 2019 | 1357 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 862 | 0.110 |
Why?
|
| Vasodilation | 1 | 2016 | 944 | 0.110 |
Why?
|
| Complex Mixtures | 1 | 2012 | 28 | 0.110 |
Why?
|
| Microsomes, Liver | 1 | 2012 | 173 | 0.100 |
Why?
|
| Carnitine | 2 | 2023 | 246 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2024 | 1965 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2016 | 1125 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1312 | 0.090 |
Why?
|
| Risk Factors | 4 | 2023 | 72290 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8301 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1863 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2022 | 21746 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2077 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13989 | 0.070 |
Why?
|
| Triglycerides | 1 | 2013 | 2454 | 0.070 |
Why?
|
| Overweight | 1 | 2016 | 2371 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 503 | 0.060 |
Why?
|
| Lipids | 1 | 2015 | 3305 | 0.060 |
Why?
|
| Humans | 17 | 2024 | 744343 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4456 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2024 | 65 | 0.060 |
Why?
|
| DNA Damage | 1 | 2013 | 2432 | 0.060 |
Why?
|
| Betaine | 1 | 2023 | 87 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8480 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2016 | 7729 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12261 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3047 | 0.050 |
Why?
|
| Glyburide | 1 | 2022 | 113 | 0.050 |
Why?
|
| Choline | 1 | 2023 | 493 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 3760 | 0.050 |
Why?
|
| Animals | 8 | 2020 | 168757 | 0.050 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2020 | 13 | 0.050 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 5034 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2020 | 162 | 0.040 |
Why?
|
| Smoking | 1 | 2016 | 8987 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 109 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 2203 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2022 | 638 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 6364 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2024 | 859 | 0.040 |
Why?
|
| Tibet | 1 | 2017 | 11 | 0.040 |
Why?
|
| Atmospheric Pressure | 1 | 2017 | 47 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 62 | 0.040 |
Why?
|
| Plethysmography | 1 | 2016 | 180 | 0.040 |
Why?
|
| Bradykinin | 1 | 2016 | 214 | 0.040 |
Why?
|
| Fluconazole | 1 | 2016 | 146 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2017 | 137 | 0.030 |
Why?
|
| Nepal | 1 | 2017 | 295 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 232 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2017 | 171 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 976 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 481 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 895 | 0.030 |
Why?
|
| Forearm | 1 | 2016 | 409 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 1150 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 827 | 0.030 |
Why?
|
| Male | 8 | 2023 | 350118 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11366 | 0.030 |
Why?
|
| Phenacetin | 1 | 2012 | 14 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 2007 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 977 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 13102 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 11725 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1641 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2012 | 467 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2017 | 727 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 1869 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.020 |
Why?
|
| Mice | 4 | 2020 | 81183 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 6622 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2017 | 3588 | 0.020 |
Why?
|
| Wound Healing | 1 | 2020 | 2785 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2132 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18029 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
| Protons | 1 | 2012 | 1127 | 0.020 |
Why?
|
| Echocardiography | 1 | 2019 | 5102 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2899 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2019 | 2788 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6442 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4397 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3297 | 0.020 |
Why?
|
| Logistic Models | 1 | 2019 | 13408 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
| Aged | 3 | 2023 | 163280 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4931 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4253 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 214055 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9438 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
| Female | 3 | 2023 | 380194 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 12745 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 213383 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23403 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 29786 | 0.010 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_